Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
about
Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Ubenimex attenuates acquired s ...... ipophagy associated mechanism.
@en
Ubenimex attenuates acquired s ...... ipophagy associated mechanism.
@nl
type
label
Ubenimex attenuates acquired s ...... ipophagy associated mechanism.
@en
Ubenimex attenuates acquired s ...... ipophagy associated mechanism.
@nl
prefLabel
Ubenimex attenuates acquired s ...... ipophagy associated mechanism.
@en
Ubenimex attenuates acquired s ...... ipophagy associated mechanism.
@nl
P2093
P2860
P356
P1433
P1476
Ubenimex attenuates acquired s ...... ipophagy associated mechanism.
@en
P2093
Dexuan Gao
Mingwei Gao
Sentai Ding
Xiaoqing Wang
Zhihong Niu
Zhiyang Wang
P2860
P304
79141-79153
P356
10.18632/ONCOTARGET.13003
P407
P577
2016-11-01T00:00:00Z